This blog is closed to new posts due to inactivity. The post remains here as part of the network’s archive of useful research information. We hope you'll join the conversation by posting to an open topic or starting a new one.
 
Aiming to integrate scientific advanes and techinical innovation into publich health practice, the BRaVe initiative is a new WHO-led effot to catalyze multidisciplinary research on strategies to prevent and treat medically important respriratory virus infections. Several ISARIC investigators and members are involved with BRaVe, which published its plans in Future Virology in October 2013.
Given the enormous estimated burden of respiratory viurs infections worlwide, a substantial number of research priorities exist in order to better understand their epidemiology, pathogeneses, prevention and clinical manaagment across different populations and resource settings. New thereapuetics and specific vaccines for noninfluenza respiratory virus infections could provide enormous benefits in reducing the morbidity and mortality associated with these frequent infections, and provide the foundation for responding to newly emerging threats.
The article is available for download here: http://www.futuremedicine.com/doi/abs/10.2217/fvl.13.85